Search - tctmd.com

Displaying 541 - 560 of 610

Sort: Relevancy | Date

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Fewer Vascular Complications as TAVR Evolves

Caitlin E. Cox

January 10, 2012

News Daily News

Stress Testing More Likely Among Physicians Who Bill for Such Services

Leah Lawrence

November 27, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Industry News

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

News Industry News

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research

November 08, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

Advertisement

Live Case Procedures Just as Safe as in Daily Practice

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Fewer Vascular Complications as TAVR Evolves

Stress Testing More Likely Among Physicians Who Bill for Such Services

Polymer-free drug eluting stents result in lower in-stent late loss

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Complications After TAVR: Manageable, But Important to Consider

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

ESC Congress 2011: Drugs, Devices Work Together

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content